Conference Reports for NATAP

64rd Annual Meeting of the American Association for the Study of Liver Diseases Washington, DC Nov 1-5 2013 Back

Safety, Tolerability, and Immunogenicity of GS-4774, an HBV-Specific Therapeutic Vaccine, in Healthy Volunteers       Reported by Jules Levin AASLD Nov 1-4 2013 Wash DC   Anuj Gaggar,1 Claire Coeshott,2 David Apelian,2 Tim Rodell,2 Gong Shen,1 Mani Subramanian,1 John McHutchison1 1Gilead Sciences, Inc., Foster City, CA; 2GlobeImmune, Louisville, CO